DK1986508T3 - Fremgangsmåder og sammensætninger til behandling af felin hyperthyroidisme - Google Patents

Fremgangsmåder og sammensætninger til behandling af felin hyperthyroidisme

Info

Publication number
DK1986508T3
DK1986508T3 DK07717437.3T DK07717437T DK1986508T3 DK 1986508 T3 DK1986508 T3 DK 1986508T3 DK 07717437 T DK07717437 T DK 07717437T DK 1986508 T3 DK1986508 T3 DK 1986508T3
Authority
DK
Denmark
Prior art keywords
felin
hyperthyroidism
compositions
treating
methods
Prior art date
Application number
DK07717437.3T
Other languages
English (en)
Inventor
Karen Joy Wedekind
Dale Allen Fritsch
Chadwick Everett Dodd
Timothy Arthur Allen
Original Assignee
Hills Pet Nutrition Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hills Pet Nutrition Inc filed Critical Hills Pet Nutrition Inc
Application granted granted Critical
Publication of DK1986508T3 publication Critical patent/DK1986508T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/137Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/20Inorganic substances, e.g. oligoelements
    • A23K20/30Oligoelements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/40Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4172Imidazole-alkanecarboxylic acids, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/18Iodine; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/14Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/14Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00Food or edible material: processes, compositions, and products
    • Y10S426/805Pet food for dog, cat, bird, or fish

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK07717437.3T 2006-01-26 2007-01-26 Fremgangsmåder og sammensætninger til behandling af felin hyperthyroidisme DK1986508T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76247906P 2006-01-26 2006-01-26
PCT/US2007/061100 WO2007087623A2 (en) 2006-01-26 2007-01-26 Methods and compositions for treating feline hyperthyroidism

Publications (1)

Publication Number Publication Date
DK1986508T3 true DK1986508T3 (da) 2014-08-18

Family

ID=38093471

Family Applications (2)

Application Number Title Priority Date Filing Date
DK07717437.3T DK1986508T3 (da) 2006-01-26 2007-01-26 Fremgangsmåder og sammensætninger til behandling af felin hyperthyroidisme
DK13181373.5T DK2666366T3 (da) 2006-01-26 2007-01-26 Fremgangsmåder og sammensætninger til behandling af felin hyperthyroidisme

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK13181373.5T DK2666366T3 (da) 2006-01-26 2007-01-26 Fremgangsmåder og sammensætninger til behandling af felin hyperthyroidisme

Country Status (12)

Country Link
US (1) US8993001B2 (da)
EP (2) EP1986508B1 (da)
JP (1) JP5356831B2 (da)
CN (1) CN101374420B (da)
AU (2) AU2007207991B2 (da)
BR (1) BRPI0706691A2 (da)
CA (2) CA2636700C (da)
DK (2) DK1986508T3 (da)
ES (2) ES2534252T3 (da)
RU (2) RU2432941C2 (da)
WO (1) WO2007087623A2 (da)
ZA (1) ZA200806361B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2527125C (en) 2003-06-20 2012-02-21 Hill's Pet Nutrition, Inc. Methods for preventing hyperthyroidism in a cat and composition comprising limited iodine
US8501223B2 (en) 2003-06-20 2013-08-06 Hill's Pet Nutrition, Inc. Methods for dietary management of cats to avoid hyperthyroidism
BRPI0706691A2 (pt) 2006-01-26 2011-04-05 Hill Pet Nutrition Inc composição e kit para tratar hipertireoidismo em um felino, meio para comunicar informação ou instruções, e, usos de iodo e de selênio
AU2007249806B2 (en) * 2006-05-12 2011-07-07 Hill's Pet Nutrition, Inc. Compositions and methods for preventing or treating chronic renal failure in felines with hyperthyroidism
EP2040565B1 (en) * 2006-07-03 2013-01-02 Hill's Pet Nutrition, Inc. Copositions and methods for preventing or treating cardiovascular diseases in felines with hyperthyroidism
CN103597097B (zh) * 2011-06-15 2016-08-17 希尔氏宠物营养品公司 用于诊断和监测猫科动物的甲状腺功能亢进的组合物和方法
RU2612901C2 (ru) 2011-12-19 2017-03-13 Хилл'С Пет Ньютришн, Инк. Композиции и способы диагностики и лечения гипертиреоза у животных-компаньонов
RU2560594C2 (ru) * 2013-12-04 2015-08-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Оренбургский государственный аграрный университет" Способ коррекции тиреоидного статуса племенных крольчих-первокролок в эндемичных зонах путем комбинированного применения йода и селена
GB2527555B (en) 2014-06-25 2018-09-19 Norbrook Lab Ltd Stable methimazole liquid compositions

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880112A (en) * 1988-08-04 1989-11-14 General Electric Company Pet food container
US5017389A (en) * 1988-08-16 1991-05-21 Green Scott T Nutritional drink compositions
US5084482A (en) * 1990-04-10 1992-01-28 The Lithox Corporation Methods for inhibiting inflammatory ischemic, thrombotic and cholesterolemic disease response with methionine compounds
US6071415A (en) * 1993-06-03 2000-06-06 Purotech International Inc. Water purification system and removal of halides
US5484623A (en) * 1994-01-10 1996-01-16 Mclean; Linsey Dietary system high in oil intake for the treatment of obesity and for the lowering of saturated fats
WO1997011703A1 (fr) 1995-09-28 1997-04-03 Teijin Limited Preventif ou remede contre l'hyperthyroidie
US6245364B1 (en) * 1996-02-29 2001-06-12 International Flora Technologies, Ltd. Weight reduction method for cats and other pets
US6037173A (en) * 1997-04-11 2000-03-14 Millennium Pharmaceuticals, Inc. Isolated nucleic acid encoding TRBP
US5885592A (en) * 1997-10-29 1999-03-23 Symbollon Corporation Methods and pharmaceutical compositions for oral delivery of molecular iodine
US6596303B1 (en) 1999-03-22 2003-07-22 Mars Incorporated Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals
HUP0202723A3 (en) * 1999-09-06 2003-01-28 Effem Foods Pty Ltd Wodonga Food product and process for manufacturing same
US6506413B1 (en) * 2001-04-30 2003-01-14 Joseph C. Ramaekers Compositions for treating animal diseases and syndromes
EP1312363A1 (en) * 2001-09-28 2003-05-21 Pfizer Products Inc. Methods of treatment and kits comprising a growth hormone secretagogue
US20050019425A1 (en) * 2001-11-07 2005-01-27 Shiguang Yu Composition and method
GB0208384D0 (en) * 2002-04-11 2002-05-22 Karobio Ab Novel compounds
US7547450B2 (en) * 2002-10-24 2009-06-16 Nestec Ltd. Senior feline food
US8501223B2 (en) * 2003-06-20 2013-08-06 Hill's Pet Nutrition, Inc. Methods for dietary management of cats to avoid hyperthyroidism
CA2527125C (en) * 2003-06-20 2012-02-21 Hill's Pet Nutrition, Inc. Methods for preventing hyperthyroidism in a cat and composition comprising limited iodine
CN1809283B (zh) * 2003-06-20 2012-09-26 希尔氏宠物营养品公司 含有有限硒和碘的组合物
CA2636039C (en) * 2006-01-19 2013-03-19 Hill's Pet Nutrition, Inc. Compositions and methods for preventing or treating feline chronic kidney disease
BRPI0706691A2 (pt) 2006-01-26 2011-04-05 Hill Pet Nutrition Inc composição e kit para tratar hipertireoidismo em um felino, meio para comunicar informação ou instruções, e, usos de iodo e de selênio
AU2007249806B2 (en) * 2006-05-12 2011-07-07 Hill's Pet Nutrition, Inc. Compositions and methods for preventing or treating chronic renal failure in felines with hyperthyroidism
EP2040565B1 (en) * 2006-07-03 2013-01-02 Hill's Pet Nutrition, Inc. Copositions and methods for preventing or treating cardiovascular diseases in felines with hyperthyroidism
US20100068306A1 (en) * 2008-09-16 2010-03-18 Chin-Pao Chou Compositions for accelerating the healing response

Also Published As

Publication number Publication date
WO2007087623A2 (en) 2007-08-02
ES2534252T3 (es) 2015-04-20
ES2478215T3 (es) 2014-07-21
CA2636700A1 (en) 2007-08-02
EP2666366A1 (en) 2013-11-27
CN101374420B (zh) 2016-11-09
BRPI0706691A2 (pt) 2011-04-05
RU2521315C2 (ru) 2014-06-27
EP1986508B1 (en) 2014-05-21
CA2823751C (en) 2015-10-06
US8993001B2 (en) 2015-03-31
RU2008134707A (ru) 2010-03-10
JP2009525967A (ja) 2009-07-16
RU2009148266A (ru) 2011-06-27
RU2432941C2 (ru) 2011-11-10
US20090226540A1 (en) 2009-09-10
EP2666366B1 (en) 2015-03-11
AU2011201051A1 (en) 2011-03-31
ZA200806361B (en) 2014-10-29
EP1986508A2 (en) 2008-11-05
CA2636700C (en) 2014-09-09
JP5356831B2 (ja) 2013-12-04
DK2666366T3 (da) 2015-04-13
AU2011201051B2 (en) 2012-06-28
WO2007087623A3 (en) 2007-12-27
CN101374420A (zh) 2009-02-25
AU2007207991A1 (en) 2007-08-02
CA2823751A1 (en) 2007-08-02
AU2007207991B2 (en) 2011-08-04

Similar Documents

Publication Publication Date Title
DK2203478T3 (da) Sammensætninger og fremgangsmåder til anvendelse af antistoffer mod sclerostin
DK2087002T3 (da) Sammensætninger og fremgangsmåder til binding af sphingosin-1-phosphat
DK2001611T3 (da) Fremgangsmåde og sammensætning til oprensning af jord
DK2010501T3 (da) Imidazolbaserede forbindelser, sammensætninger omfattende disse og fremgangsmåder for deres anvendelse
DK1791791T3 (da) Fremgangsmåder og sammensætninger til behandling af vand
DK2894165T3 (da) Fremgangsmåder og sammensætninger til behandling af komplementforbundne forstyrrelser
DK2061561T3 (da) Sammensætninger til behandling af cancer
DK2323638T3 (da) Sammensætninger og fremgangsmåder til behandling af osteoartritis
DK2101819T3 (da) Fremgangsmåder, sammensætninger og kits til behandling af smerte og pruritis
DK2137537T3 (da) Sammensætninger og anvendelser til behandling af multipel sklerose
DK2099489T3 (da) Sammensætninger og fremgangsmåder til behandling af en neoplasme
DK3263589T5 (da) Peptidsekvenser og sammensætninger
DK2066339T3 (da) Sammensætninger og fremgangsmåder til forstærkning af immunreaktioner
DK2212070T3 (da) Fremgangsmåde til behandling af træ
DK2187880T3 (da) Sammensætninger og fremgangsmåder til behandling af makuladegeneration
DK3207941T3 (da) Fremgangsmåder og sammensætninger på basis af diphtheritoksin-interleukin-3-konjugater
DK2081669T3 (da) Fremgangsmåde og anordning til fremstilling af granulater
DK2032156T3 (da) Sammensætninger og fremgangsmåder til levering af oxygen
DK1858864T3 (da) Stabiliserede sammensætninger af flygtige alkyleringsmidler og fremgangsmåder til anvendelse deraf
DK2155188T3 (da) Fremgangsmåder og sammensætninger til behandling af tilbagevendende kræft
BRPI0809573A8 (pt) composição, e, método
DK1986508T3 (da) Fremgangsmåder og sammensætninger til behandling af felin hyperthyroidisme
DK2068930T3 (da) Sammensætninger og fremgangsmåder under anvendelse af anti-CS1-antistoffer til at behandle multiple myelomer
DK3263112T3 (da) Sammensætninger og fremgangsmåder til undertrykkelse af endometriproliferationer
DK2865422T3 (da) Alpha-msh-derivater til behandling af fotodermatoser